Pharmaceutical Nanotechnology for the Treatment of Leishmaniasis and Chagas Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 10 January 2025 | Viewed by 106
Special Issue Editors
Interests: nanotechnology; nanoparticles; nanoformulation
Special Issues, Collections and Topics in MDPI journals
Interests: phytomedicines; phytochemistry; nanoformulation of natural products; nanobiotechnology
Special Issue Information
Dear Colleagues,
The World Health Organization (WHO) defines neglected tropical diseases (NTDs) as a diverse group of healthy conditions caused by a variety of pathogens and associated with devastating health, social and economic consequences. NTDs are mainly prevalent among poor communities in tropical areas, although some have a much larger geographical distribution, reaching developed countries. It is estimated that NTDs affect more than 1 billion people, while the number of people requiring NTD interventions (both preventive and curative) is 1.6 billion. Among NTDs, leishmaniasis and Chagas disease are two of the most relevant. Currently, the treatment of both parasite infections is still problematic, where few alternative drugs are available for use in clinical settings, and they present serious concerns such as parasite resistance, debilitating side effects, cost of treatment, the need for hospitalization and/or patient continuous monitoring. Pharmaceutical nanotechnology is being employed to overcast many of the problems associated with the drugs in current use. Nanomedicines are believed to expand drug absorption, improve biodistribution, target selected cells or organs, and reduce side effects and general toxicity, as well as help in the introduction of new drug candidates from biological or synthetic origins.
The aim of this Special Issue of Pharmaceutics is to collect research and review papers related to the application of pharmaceutical nanotechnology tools directed to the treatment of leishmaniasis and Chagas diseases. We welcome articles dealing with all aspects nanotechnology and invite researchers and drug developers to publish their original research or review articles with expert opinions and perspectives in the area of both NTDs.
Prof. Dr. Orlando David Henrique dos Santos
Dr. Gustavo Henrique Bianco de Souza
Dr. Janaína Brandão Seibert
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoformulation
- leishmaniasis
- chagas disease
- nanotechnology
- drug toxicity
- bioavailability
- nanomedicine
- dosage form
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
